Validation of an Automated Cell-Based Bioluminescent TNFa Blocker Bioassay

Poster   Feb 16, 2012

 
Validation of an Automated Cell-Based Bioluminescent TNFa Blocker Bioassay
 
View Poster
 
 

Brad Larson, Tracy Worzella, Rich Moravec, Neal Cosby, Frank Fan, Teresa Surowy and Peter Banks

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 

This content appears on:

Analysis & Separations Biopharma Drug Discovery

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

OTHER POSTERS

Applications of chemically modified synthetic guide RNA for CRISPR-Cas9 genome editing

Poster

Our results indicate that MS modifications are required for experiments with co-electroporation of Cas9 mRNA and synthetic gRNA, yet have no impact on editing efficiency when delivered with lipid-based transfection reagents.

READ MORE

Novel lead optimization strategy of BACE I inhibitors for the treatment of Alzheimer’s disease by Quantitative Structure-Activity Relationship (QSAR) and Physiologically-Based Pharmacokinetics (PBPK) modeling

Poster

In this study, we introduce an innovative in silico-based high throughput lead optimization strategy with QSAR and PBPK modelings using StarDrop™, ADMET predictor® and GastroPlus®.

READ MORE

Touching BACE. How Inhibiting β-Amyloid Production by Steric Hindrance with a Novel Immunotherapy Improves Memory in PDAPP Mice

Poster

The work presented in this poster aims to assess whether intracerebroventricular (ICV) administration of 2B3 alleviated age dependent memory deficits in PDAPP mice and to determine whether 2B3 altered APP metabolism and NMDA receptor phosphorylation ex vivo.

READ MORE

 

Comments | 0 ADD COMMENT